Experts, including McCoy, have suggested that such weight rebounds could leave people in an unhealthier state than they were before treatment
People Who See the Biggest Drops Youre more likely to see significant blood pressure reductions if you: Have higher baseline blood pressure (140/90 or above) Carry extra weight, especially around your belly Have type 2 diabetes Are younger (under 65) Take higher doses of the medication Even people with normal blood pressure at the start often see small reductions
Picture this: testing a new swimming pool by only allowing people who cant swim to stand on the deck, declaring it safe based on the zero drownings, and then opening it to the public with a sign that says PROBABLY FINE. We then gave it to millions of people, many of whom have brain chemistry that is already struggling, and we are now acting confused about the results
Plug in the defaults to see what each dose delivers: Skincare (2.5 mL water with GHK-Cu anchor) Payload: GHK-Cu 2 mg BPC-157 0.4 mg TB-4 0.4 mg
Transparent in theory, complex in practice
MOTS-c is a mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome that improves cellular energy metabolism, insulin sensitivity, and exercise capacity through AMPK activation and metabolic regulation